Gemtuzumab Ozogamicin (GO) Inclusion to Induction Chemotherapy Eliminates Leukemic Initiating Cells and Significantly Improves Survival in Mouse Models of Acute Myeloid Leukemia

por Zhang, Cathy C, Yan, Zhengming, Pascual, Bernadette, Jackson-Fisher, Amy, Huang, Donghui Stephen, Zong, Qing, Elliott, Mark, Fan, Conglin, Huser, Nanni, Lee, Joseph, Sung, Matthew, Sapra, Puja
Publicado 2017